Pharmaceutical Expenditure Forecast Revised Upwards

BMI View: China's status as the premier emerging pharmaceutical market has been reinforced following an upgrade of the country's macroeconomic prospects. Our Country Risk team now expects the country to post real GDP growth of 9.7% in 2010. Although this figure is above the 8.8% previously forecast it is still below the consensus of 10.0%. Therefore, BMI's pharmaceutical expenditure projection for China continues to have a lower trajectory compared with other data

To read the full article, please choose one of the following options: